BCLAF1 is a multifunctional transcriptional regulator and post-transcriptional factor with context-dependent roles in disease. Originally characterized as a death-promoting transcriptional repressor 1, BCLAF1 has evolved as a recognized player in diverse biological processes including DNA damage response, pre-mRNA splicing, and mRNA metabolism 2. The protein functions through multiple mechanisms: it regulates transcription factor activity (notably MYC through BCKDK-mediated phosphorylation at serine 285) 3, controls chr6 accessibility by activating RNA polymerase II 4, and stabilizes proteins like PD-L1 by competing with E3 ligases for binding 5. In cancer biology, BCLAF1 demonstrates context-dependent effects—acting as a tumor promoter in esophageal and lung cancers by enhancing glycolysis and proliferation 6, while potentially suppressing tumors in other contexts 1. Beyond malignancy, BCLAF1 influences macrophage-mediated MAPK signaling in systemic sclerosis-related interstitial lung disease, where it contributes to oxidative stress-driven lung fibrosis 7. Nuclear p85β cooperates with BCLAF1 in transcriptional regulation, including positive autoregulation of BCLAF1 itself 8. These diverse roles establish BCLAF1 as a pleiotropic regulator warranting consideration as a therapeutic target across multiple disease contexts.